Discover the groundbreaking treatment being developed by Demei Pharmaceutical Technology Co., Ltd. - Exendin-This innovative drug shows great promise in the management of type 2 diabetes and obesity. Exendin-4, derived from the saliva of the Gila monster, is a potent agonist of the glucagon-like peptide-1 (GLP-receptor, leading to improved glucose-dependent insulin secretion and reduced glucagon secretion. This results in better control of blood sugar levels and reduction in body weight, Clinical studies have demonstrated the efficacy and safety of Exendin-4, making it a potential game-changer in the treatment of metabolic disorders. Demei Pharmaceutical Technology Co., Ltd. is committed to bringing high-quality and effective medications to patients around the world, and Exendin-4 is a shining example of the company's dedication to innovation and excellence in pharmaceutical research and development, With Exendin-4, Demei Pharmaceutical Technology Co., Ltd. aims to offer a new and improved treatment option for individuals struggling with type 2 diabetes and obesity, ultimately improving their quality of life. Stay tuned as we continue to progress towards making Exendin-4 available to those in need
Please feel free to give your inquiry in the form below We will reply you in 24 hours